| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,516 |
5,334 |
$292K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,919 |
2,509 |
$209K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,464 |
2,009 |
$169K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,166 |
1,002 |
$89K |
| 90671 |
|
391 |
276 |
$42K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,400 |
2,042 |
$38K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
412 |
341 |
$31K |
| 90698 |
|
1,656 |
1,304 |
$21K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
920 |
479 |
$20K |
| 96127 |
|
1,331 |
1,202 |
$19K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
189 |
168 |
$16K |
| 90680 |
|
1,260 |
976 |
$15K |
| 90670 |
|
1,100 |
966 |
$15K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
830 |
694 |
$12K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
300 |
246 |
$11K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
771 |
623 |
$10K |
| 99173 |
|
1,184 |
1,052 |
$9K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
199 |
187 |
$7K |
| 90744 |
|
497 |
435 |
$6K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
42 |
41 |
$6K |
| 99460 |
|
149 |
149 |
$6K |
| 99381 |
|
64 |
64 |
$6K |
| 90686 |
|
497 |
435 |
$5K |
| 81002 |
|
1,064 |
934 |
$3K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
74 |
67 |
$2K |
| 87807 |
|
165 |
114 |
$2K |
| 90734 |
|
69 |
32 |
$1K |
| 90633 |
|
112 |
103 |
$1K |
| 99462 |
|
38 |
27 |
$794.13 |
| 90677 |
|
38 |
38 |
$634.98 |
| 90716 |
|
75 |
58 |
$557.22 |
| 90707 |
|
70 |
53 |
$474.12 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
13 |
12 |
$456.17 |
| 36416 |
|
82 |
75 |
$295.20 |
| 96160 |
|
42 |
42 |
$292.00 |
| 90710 |
|
12 |
12 |
$200.52 |
| 85018 |
|
87 |
79 |
$197.52 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
404 |
380 |
$48.54 |
| 94760 |
|
22 |
15 |
$39.06 |
| 90461 |
|
258 |
250 |
$32.60 |
| 81003 |
|
13 |
12 |
$28.34 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
51 |
26 |
$0.00 |